Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Yun Sheng Yang, Xinru Tan, Xiaojie Yang, Chujun Weng, Rongwen Yu, Qi Dong Zhao, Shichao Quan
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature
10.1016/j.cld.2019.07.004 · 2019
North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension
10.1016/j.cgh.2021.07.018 · 2022
Clearing the confusion over hepatic encephalopathy after tips creation: incidence, prognostic factors, and clinical outcomes
10.1007/s10620-014-3391-0 · 2015
Cellular pathogenesis of hepatic encephalopathy: an update
10.3390/biom13020396 · 2023
Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt according to its severity and temporal grading classification
10.1007/s11547-017-0770-6 · 2017
Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges
10.3390/jcm9113784 · 2020
TIPS: 25 years later
10.1016/j.jhep.2013.06.014 · 2013
Diagnosis and management of hepatic encephalopathy: The French recommendations
10.1111/liv.15510 · 2023
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States From 2005 to 2009
10.1016/j.cgh.2012.05.016 · 2012
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
10.1016/j.jhep.2022.06.001 · 2022
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt
10.3748/wjg.v22.i25.5780 · 2016
History of hepatic encephalopathy is not a contraindication to transjugular intrahepatic portosystemic shunt placement for refractory ascites
10.14309/ctg.0000000000000378 · 2021
Prediction and risk factors for prognosis of cirrhotic patients with hepatic encephalopathy
10.1155/2021/5623601 · 2021
ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
10.1016/j.jhepr.2021.100347 · 2021
Current approaches to hepatic encephalopathy
10.1016/j.aohep.2022.100757 · 2022
MELD 3.0: the model for end-stage liver disease updated for the modern era
10.1053/j.gastro.2021.08.050 · 2021
Development and validation of prognostic models to estimate the risk of overt hepatic encephalopathy after tips creation: a multicenter study
10.14309/ctg.0000000000000461 · 2022
Using machine learning methods to predict 28-day mortality in patients with hepatic encephalopathy
10.1186/s12876-023-02753-z · 2023
Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation
10.1007/s00270-021-02907-0 · 2021
Radiomics-based classification models for HBV-related cirrhotic patients with covert hepatic encephalopathy
10.1002/brb3.1970 · 2021
A radiomics model of liver CT to predict risk of hepatic encephalopathy secondary to hepatitis B related cirrhosis
10.1016/j.ejrad.2020.109201 · 2020
CT-based radiomics model for preoperative prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
10.1259/bjr.20210792 · 2022
3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study
10.1007/s12072-023-10570-5 · 2023
Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt
10.4240/wjgs.v15.i8.1564 · 2023
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt: a multicentre randomised, double blind, placebo controlled trial
10.1136/bmjgast-2020-000531 · 2020
Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
10.3748/wjg.v27.i5.416 · 2021
Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt: A panacea for post-TIPS hepatic encephalopathy?
10.1002/hep.32525 · 2022
Transjugular intrahepatic portosystemic shunt through left branch versus right branch of portal vein: a meta-analysis
10.1007/s00261-020-02789-9 · 2021
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
10.1136/gutjnl-2019-320221 · 2020
Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation
10.1186/s12876-022-02447-y · 2022
Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management
10.1007/s00270-021-03045-3 · 2022
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
10.1016/j.jhep.2018.03.024 · 2018
Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis
10.14309/ajg.0000000000000762 · 2020
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
10.1016/j.cld.2011.12.008 · 2012
10.1002/hep.27210
10.1002/hep.27210
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
10.1097/hc9.0000000000000096 · 2023
Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision
10.1007/s00270-018-1992-2 · 2018
Review article: post-TIPSS hepatic encephalopathy—current knowledge and future perspectives
10.1111/apt.16825 · 2022
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis
10.1042/bsr20222524 · 2023
Epidemiology of Hepatic Encephalopathy
10.1016/j.cld.2020.01.001 · 2020
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
10.1053/he.2000.5852 · doi-reference
Large language models for structured reporting in radiology: performance of GPT-4, ChatGPT-3.5, Perplexity and Bing
10.1007/s11547-023-01651-4 · doi-reference
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
10.1186/s13045-023-01514-5 · doi-reference
Overview of Chatbots with special emphasis on artificial intelligence-enabled ChatGPT in medical science
10.3389/frai.2023.1237704 · doi-reference
How Does ChatGPT Perform on the United States Medical Licensing Examination? The Implications of Large Language Models for Medical Education and Knowledge Assessment
10.2196/45312 · doi-reference
Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease
10.14309/ajg.0000000000000662 · doi-reference
Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure
10.1186/s12876-020-01191-5 · doi-reference
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease
10.1016/j.cgh.2019.12.025 · doi-reference
Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to Help Humans
10.1002/hep.31777 · doi-reference
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
10.1002/hep.31750 · doi-reference
10.1038/s41591-018-0316-z
10.1038/s41591-018-0316-z · doi-reference
Modeling and analyzing single-cell multimodal data with deep parametric inference
10.1093/bib/bbad005 · doi-reference
Revolutionizing Infection Risk Scoring: An Ensemble "From Weak to Strong" Deduction Strategy and Enhanced Point-of-Care Testing Tools
10.1002/aisy.202300224 · doi-reference
Development and validation of radiomics model built by incorporating machine learning for identifying liver fibrosis and early-stage cirrhosis
10.1097/cm9.0000000000001113 · doi-reference
Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver
10.1148/radiol.2018180763 · doi-reference
Measuring depression severity based on facial expression and body movement using deep convolutional neural network
10.3389/fpsyt.2022.1017064 · doi-reference
Development and validation of an interpretable radiomic nomogram for severe radiation proctitis prediction in postoperative cervical cancer patients
10.3389/fmicb.2022.1090770 · doi-reference
Gene function and cell surface protein association analysis based on single-cell multiomics data
10.1016/j.compbiomed.2023.106733 · doi-reference
10.1016/j.compbiomed.2023.107596
10.1016/j.compbiomed.2023.107596 · doi-reference
A Bayesian mixture model for predicting the COVID-19 related mortality in the United States
10.4269/ajtmh.20-1147 · doi-reference
Quantitative investigation of inappropriate regression model construction and the importance of medical statistics experts in observational medical research: a cross-sectional study
10.1136/bmjopen-2017-021129 · doi-reference
Uncertainty quantification in multivariable regression for material property prediction with Bayesian neural networks
10.1038/s41598-024-61189-x · doi-reference
10.1002/aisy.202400304
10.1002/aisy.202400304 · doi-reference
The application of large language models in medicine: A scoping review
10.1016/j.isci.2024.109713 · doi-reference
10.1001/jama.2023.8288
10.1001/jama.2023.8288 · doi-reference
10.3390/ijerph20043378
10.3390/ijerph20043378 · doi-reference
Evaluation of large language models as a diagnostic aid for complex medical cases
10.3389/fmed.2024.1380148 · doi-reference
Lung cancer nodules detection via an adaptive boosting algorithm based on self‐normalized multiview convolutional neural network
10.1155/2022/5682451 · doi-reference
A framework for validating AI in precision medicine: considerations from the European ITFoC consortium
10.1186/s12911-021-01634-3 · doi-reference
Shortcut learning in medical AI hinders generalization: method for estimating AI model generalization without external data
10.1038/s41746-024-01118-4 · doi-reference
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models
10.1186/s12859-022-04684-0 · doi-reference
A novel decentralized federated learning approach to train on globally distributed, poor quality, and protected private medical data
10.1038/s41598-022-12833-x · doi-reference
10.1001/jamainternmed.2018.3763
10.1001/jamainternmed.2018.3763 · doi-reference
Artificial intelligence (AI) systems for interpreting complex medical datasets
10.1002/cpt.650 · doi-reference
Explainable AI for retinoblastoma diagnosis: interpreting deep learning models with LIME and SHAP
10.3390/diagnostics13111932 · doi-reference
An interpretable machine learning model for diagnosis of Alzheimer's disease
10.7717/peerj.6543 · doi-reference
Machine Learning Insights: Predicting Hepatic Encephalopathy After TIPS Placement
10.1007/s00270-023-03593-w · doi-reference
Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year
10.1007/s00270-021-02961-8 · doi-reference
Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation
10.2214/ajr.19.21655 · doi-reference
Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue
10.1016/j.acra.2023.10.013 · doi-reference